Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Orthopaedics and Related Research®
Published in: Clinical Orthopaedics and Related Research® 3/2012

01-03-2012 | Symposium: 2010 Musculoskeletal Tumor Society

Early Complications of High-dose-rate Brachytherapy in Soft Tissue Sarcoma: A Comparison With Traditional External-beam Radiotherapy

Authors: Cynthia L. Emory, MD, Corey O. Montgomery, MD, Benjamin K. Potter, MD, Martin E. Keisch, MD, Sheila A. Conway, MD

Published in: Clinical Orthopaedics and Related Research® | Issue 3/2012

Login to get access

Abstract

Background

Radiotherapy and surgery are routinely utilized to treat extremity soft tissue sarcoma. Multiple radiation modalities have been described, each with advantages and disadvantages, without one modality demonstrating clear superiority over the others.

Questions/purposes

We determined the overall initial complication rate in patients receiving surgery and radiotherapy, which specific complications were found when comparing different modalities, and whether combination therapy increased the overall rate of complications compared with surgery and single-modality radiotherapy.

Patients and Methods

We retrospectively reviewed the records of 190 patients who received external-beam radiotherapy (141 patients), high-dose-rate brachytherapy (37 patients), or both (12 patients). We evaluated 100 men and 90 women (mean age, 57 years; range, 18–94 years) for tumor size and subtype, comorbidities, stage, grade, margin of resection, type of adjuvant treatment, and complications. Minimum followup was 3 months (mean, 40 months; range, 3–155 months).

Results

The most frequent early complications in the high-dose-rate brachytherapy cohort were infection, cellulitis, and seroma and/or hematoma. In the external-beam radiotherapy cohort, chronic edema, fibrosis, and chronic radiation dermatitis were more frequently encountered. The total number of early complications and overall incidence of major complications requiring further surgery were similar among the three cohorts, but a larger number of patients in the high-dose-rate brachytherapy group required subsequent surgery for infection compared with the external-beam radiotherapy group.

Conclusions

High-dose-rate brachytherapy decreases radiation exposure and allows shorter duration of treatment compared with traditional external-beam radiotherapy but has a higher perioperative wound complication rate.

Level of Evidence

Level III, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.
Literature
1.
Alekhteyar KM, Porter AT, Herskovic AM, Ryan J, Orton CG, Forman JD, Ahmad K. Preliminary results of hyperfractionated high dose rate brachytherapy in soft tissue sarcoma. Endocuriether Hypertherm Oncol. 1994;10:179–184.
2.
Alektiar KM, Velasco J, Zelefsky MJ, Woodruff JM, Lewis JJ, Brennan MF. Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremity. Int J Radiat Oncol Biol Phys. 2000;48:1051–1058.PubMedCrossRef
3.
Alektiar KM, Zelefsky MJ, Brennan MF. Morbidity of adjuvant brachytherapy in soft tissue sarcoma of the extremity and superficial trunk. Int J Radiat Oncol Biol Phys. 2000;47:1273–1279.PubMedCrossRef
4.
Andrews SF, Anderson PR, Eisenberg BL, Hanlon AL, Pollack A. Soft tissue sarcomas treated with postoperative external beam radiotherapy with and without low-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 2004;59:475–480.PubMedCrossRef
5.
Arbeit JM, Hilaris BS, Brennan MF. Wound complications in the multimodality treatment of extremity and superficial sarcomas. J Clin Oncol. 1987;5:480–488.PubMed
6.
Aronowitz JN, Pohar SS, Liu L, Haq R, Damron TA. Adjuvant high dose rate brachytherapy in the management of soft tissue sarcoma: a dose-toxicity analysis. Am J Clin Oncol. 2006;29:508–513.PubMedCrossRef
7.
Cheng EY, Dusenbery KE, Winters MR, Thompson RC. Soft tissue sarcomas: preoperative versus postoperative radiotherapy. J Surg Oncol. 1996;61:90–99.PubMedCrossRef
8.
Chun M, Kang S, Kim BS, Oh YT. High dose rate interstitial brachytherapy in soft tissue sarcoma: technical aspects and results. Jpn J Clin Oncol. 2001;31:279–283.PubMedCrossRef
9.
Crownover RL, Marks KE. Adjuvant brachytherapy in the treatment of soft-tissue sarcomas. Hematol Oncol Clin North Am. 1999;13:595–607.PubMedCrossRef
10.
Dalton RR, Lanciano RM, Hoffman JP, Eisenberg BL. Wound complications after resection and immediate postoperative brachytherapy in the management of soft-tissue sarcomas. Ann Surg Oncol. 1996;3:51–56.PubMedCrossRef
11.
Davis AM, O’Sullivan B, Turcotte R, Bell R, Catton C, Chabot P, Wunder J, Hammond A, Benk V, Kandel R, Goddard K, Freeman C, Sadura A, Zee B, Day A, Tu D, Pater J; Canadian Sarcoma Group; NCI Canada Clinical Trial Group Randomized Trial. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol. 2005;75:48–53.PubMedCrossRef
12.
13.
Fein DA, Lee WR, Lianciano RM, Corn BW, Herbert SH, Hanlon AL, Hoffman JP, Eisenberg BL, Coia LR. Management of extremity soft tissue sarcomas with limb-sparing surgery and postoperative irradiation: do total dose, overall treatment time, and the surgery-radiotherapy interval impact on local control? Int J Radiat Oncol Biol Phys. 1995;32:969–976.PubMedCrossRef
14.
Gerrand CH, Bell RS, Wunder S, Kandel RA, O’Sullivan B, Catton CN, Griffin AM, Davis AM. The influence of anatomic location on outcome in patients with soft tissue sarcoma of the extremity. Cancer. 2003;97:485–492.PubMedCrossRef
15.
Gilbert NF, Cannon CP, Lin PP, Lewis VO. Soft-tissue sarcoma. J Am Acad Orthop Surg. 2009;17:40–47.PubMed
16.
Green FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M. AJCC Cancer Staging Manual. 6th ed. Philadelphia, PA: Lippincott-Raven; 2002.
17.
Harrison LB, Franzese F, Gaynor JJ, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in the management of completely resected soft tissue sarcomas of the extremity and superficial trunk. Int J Radiat Oncol Biol Phys. 1993;27:259–265.PubMed
18.
Hilaris BB, Bodner WR, Mastoras CA. Role of brachytherapy in adult soft tissue sarcomas. Semin Surg Oncol. 1997;13:196–203.PubMedCrossRef
19.
Itami J, Sumi M, Beppu Y, Chuman H, Kawai A, Murakami N, Morota M, Mayahara H, Yoshimura R, Ito Y, Kagami Y. High-dose rate brachytherapy alone in postoperative soft tissue sarcomas with close or positive margins. Brachytherapy. 2010;9:349–353.PubMedCrossRef
20.
Jones JJ, Catton CN, O’Sullivan B, Couture J, Heisler RL, Kandel RA, Swallow CJ. Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma. Ann Surg Oncol. 2002;9:346–354.PubMedCrossRef
21.
Kaled MA, Brennan M, Healey J, Singer S. Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity. J Clin Oncol. 2008;26:3340–3344.
22.
Kaled MA, Hong L, Brennan M, Della-Bianca C, Singer S. Intensity modulated radiation therapy for primary soft tissue sarcoma of the extremity: preliminary results. Int J Radiat Oncol Biol Phys. 2007;68:458–464.CrossRef
23.
Koizumi M, Inoue T, Yamazaki H, Teshima T, Tanaka E, Yoshida K, Imai A, Shiomi H, Kagawa K, Araki N, Kuratsu S, Uchida A, Inoue T. Perioperative fractionated high-dose rate brachytherapy for malignant bone and soft tissue tumors. Int J Radiat Oncol Biol Phys. 1999;43:989–993.PubMedCrossRef
24.
Kubo T, Sugita T, Shimose S, Matsuo T, Hirao K, Kimura H, Kenjo M, Ochi M. Nerve tolerance to high-dose-rate brachytherapy in patients with soft tissue sarcoma: a retrospective study. BMC Cancer. 2005;5:79.PubMedCrossRef
25.
Laskar S, Bahl G, Puri A, Agarwal MG, Muckaden M, Patil N, Jambhekar N, Gupta S, Deshpande DD, Shrivastava SK, Dinshaw KA. Perioperative interstitial brachytherapy for soft tissue sarcomas: prognostic factors for long term results of 155 patients. Ann Surg Oncol. 2007;14:560–567.PubMedCrossRef
26.
Lee HY, Cordeiro PG, Mehrara BJ, Singer S, Alektiar KM, Hu QY, Disa JJ. Reconstruction after soft tissue sarcoma resection in the setting of brachytherapy: a 10 year experience. Ann Plast Surg. 2004;52:486–492.PubMedCrossRef
27.
Lewis JJ, Leung D, Espat J, Woodruff JM, Brennan MF. Effects of reresection in extremity soft tissue sarcoma. Ann Surg. 2000;231:655–663.PubMedCrossRef
28.
Livi L, Santoni R, Paiar F, Bastiani P, Beltrami G, Caldora P, Capanna R, De Biase P, Detti B, Fondelli S, Maldolesi E, Pertici M, Polli C, Simontacchi G, Biti G. Late treatment-related complications in 214 patients with extremity soft-tissue sarcoma treated by surgery and postoperative radiation therapy. Am J Surg. 2006;191:230–234.PubMedCrossRef
29.
Nag S, Shasha D, Janjan N, Petersen I, Zaider M; The American Brachytherapy Society. The American Brachytherapy Society recommendations for brachytherapy of soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2001;49:1033–1043.PubMedCrossRef
30.
O’Connor M, Pritchard DJ, Gunderson LL. Integration of limb-sparing surgery, brachytherapy, and external-beam irradiation in the treatment of soft-tissue sarcomas. Clin Orthop Relat Res. 1993;289:73–80.PubMed
31.
Ormsby MV, Hilaris BS, Nori D, Brennan MF. Wound complications of adjuvant radiation therapy in patients with soft-tissue sarcomas. Ann Surg. 1989;210:93–99.PubMedCrossRef
32.
O’Sullivan B, Davis AM, Turcotte R, Bell R, Catton C, Chabot P, Wunder J, Kandel R, Goddard K, Sadura A, Pater J, Zee B. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2002;359:2235–2241.PubMedCrossRef
33.
Petera J, Soumarova R, Růžičková J, Neumanová R, Dušek L, Sirák I, Mačingová Z, Paluska P, Kašaova L, Hodek M, Vošmik M. Perioperative hyperfractionated high-dose rate brachytherapy for the treatment of soft tissue sarcomas: multicentric experience. Ann Surg Oncol. 2010;17:206–210.PubMedCrossRef
34.
Pisters PW, Harrison LB, Leung DH, Woodruff JM, Casper CS, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol. 1996;14:859–868.PubMed
35.
Pisters PW, Harrison LB, Woodruff JM, Gaynor JJ, Brennan MF. A prospective randomized trial of adjuvant brachytherapy in the management of low-grade soft tissue sarcomas of the extremity and superficial trunk. J Clin Oncol. 1994;12:1150–1155.PubMed
36.
Pollack A, Zagars GK, Goswitz MS, Pollock RA, Feig BW, Pisters PW. Preoperative vs. postoperative radiotherapy in the treatment of soft tissue sarcomas: a matter of presentation. Int J Radiat Oncol Biol Phys. 1998;42:517–523.PubMedCrossRef
37.
Stinson SF, Delaney TF, Greenberg J, Yang JC, Lampert MH, Hicks JE, Venzon D, White DE, Rosenberg SA, Glatstein EJ. Acute and long-term effects on limb function of combined modality limb sparing therapy for extremity soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 1991;21:1493–1499.PubMedCrossRef
38.
Strander H, Turesson I, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in soft tissue sarcomas. Acta Oncol. 2003;42:516–531.PubMedCrossRef
39.
Tepper JE, Suit HD. Radiation therapy of soft tissue sarcomas. Cancer. 1985;55(9 suppl):2273–2277.PubMedCrossRef
40.
Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, de Mascarel A, Goussot JF, David M, Bonichon F, Lagarde C. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer. 1984;33:37–42.PubMedCrossRef
41.
Willett CG, Czito BG, Tyler DS. Intraoperative radiation therapy. J Clin Oncol. 2007;25:970–977.CrossRef
42.
Yang JC, Chang AE, Baker AR, Sindelar WF, Danforth DN, Topalian SL, DeLaney T, Glatstein E, Steinberg SM, Merino MJ, Rosenberg SA. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998;16:197–203.PubMed
Metadata
Title
Early Complications of High-dose-rate Brachytherapy in Soft Tissue Sarcoma: A Comparison With Traditional External-beam Radiotherapy
Authors
Cynthia L. Emory, MD
Corey O. Montgomery, MD
Benjamin K. Potter, MD
Martin E. Keisch, MD
Sheila A. Conway, MD
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Clinical Orthopaedics and Related Research® / Issue 3/2012
Print ISSN: 0009-921X
Electronic ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-011-2106-5

Other articles of this Issue 3/2012

Clinical Orthopaedics and Related Research® 3/2012 Go to the issue

Symposium: Complex Knee Ligament Surgery

Posterior Cruciate Ligament and Posterolateral Corner Deficiency Results in a Reverse Pivot Shift

Clinical Research

Are Patient-specific Cutting Blocks Cost-effective for Total Knee Arthroplasty?

Symposium: Complex Knee Ligament Surgery

Risk Factors for Peroneal Nerve Injury and Recovery in Knee Dislocation

Basic Research

Repeated Freeze-thaw Cycles Do Not Alter the Biomechanical Properties of Fibular Allograft Bone

Symposium: Complex Knee Ligament Surgery

Revision ACL Reconstruction in Skeletally Mature Athletes Younger Than 18 Years

Symposium: 2010 Musculoskeletal Tumor Society

Endoprostheses Last Longer Than Intramedullary Devices in Proximal Femur Metastases